JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 8, 2005; DOI: 10.1124/jpet.104.080754


0022-3565/05/3132-855-861$20.00
JPET 313:855-861, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.080754v1
313/2/855    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, S. P.
Right arrow Articles by Zimniak, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S. P.
Right arrow Articles by Zimniak, P.

TOXICOLOGY

Mutagenic Effects of 4-Hydroxynonenal Triacetate, a Chemically Protected Form of the Lipid Peroxidation Product 4-Hydroxynonenal, as Assayed in L5178Y/Tk+/– Mouse Lymphoma Cells

Sharda P. Singh, Tao Chen, Ling Chen, Nan Mei, Eric McLain, Victor Samokyszyn, John J. Thaden, Martha M. Moore, and Piotr Zimniak

Department of Pharmacology and Toxicology (S.P.S., E.M., V.S., P.Z.) and Department of Geriatrics (J.J.T.), University of Arkansas for Medical Sciences, and Central Arkansas Veteran's Healthcare System (S.P.S., J.J.T., P.Z.), Little Rock, Arkansas; Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas (T.C., L.C., N.M., M.M.M.); and College of Life Science and Technology, Shanghai Jiao Tong University, Shanghai, China (L.C.)

The lipid peroxidation product 4-hydroxynon-2-enal (4-HNE) is cytotoxic and genotoxic at superphysiological concentrations. To characterize the mechanism of action of 4-HNE, we assessed genotoxic damage by 4-HNE and by 4-HNE triacetate [4-HNE(Ac)3] using the mouse lymphoma assay that measures the mutant frequency in the Tk gene. As a strong electrophile, 4-HNE reacts readily with nucleophilic centers on cellular components. When added extracellularly, it may react preferentially with proteins in culture medium or on the cell surface and not reach deeper cellular targets such as nuclear DNA. Therefore, 4-HNE(Ac)3, a protected form of 4-HNE that is metabolically converted to 4-HNE in cells (Neely MD, Amarnath V, Weitlauf C, and Montine TJ, Chem Res Toxicol 15:40–47, 2002), was assayed in addition to 4-HNE. When added in serum-containing medium, 4-HNE was not mutagenic in the mouse lymphoma assay up to 38 µM (cytotoxicity = 13%). In contrast, exposure to 4-HNE(Ac)3, which mimics intracellular formation of 4-HNE, resulted in dose-dependent induction of mutations. At 17 µM 4-HNE(Ac)3 (cytotoxicity = 33%), the mutant frequency was 719 x 10–6 (>7-fold higher than the spontaneous mutant frequency). Loss of heterozygosity analysis in the Tk mutants revealed that the majority of mutations induced by 4-HNE(Ac)3 resulted from clastogenic events affecting a large segment of the chromosome. The results indicate that, in the presence of serum that approximates physiological conditions, 4-HNE generated intracellularly but not extracellularly is a strong mutagen via a clastogenic action at concentrations that may occur during oxidative stress.


Received November 14, 2004; accepted February 3, 2005.

Address correspondence to: Dr. Piotr Zimniak, Department of Pharmacology and Toxicology, #638, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205. E-mail zimniakpiotr{at}uams.edu




This article has been cited by other articles:


Home page
Toxicol SciHome page
N. Mei, Q. Xia, L. Chen, M. M. Moore, P. P. Fu, and T. Chen
Photomutagenicity of Retinyl Palmitate by Ultraviolet A Irradiation in Mouse Lymphoma Cells
Toxicol. Sci., November 1, 2005; 88(1): 142 - 149.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.